Home
Browse All Titles
Sign In
Browse All Titles
The Maudsley Prescribing Guidelines in Psychiatry
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com
◀
*
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Z
▶
View All
perioperative bleeding risks with non-SSRI antidepressants
perioperative blood loss, SSRI risks
Persistent atrial fibrillation
Personal and cultural beliefs, influencing adherence
Personality disorders
antipsychotic prescriptions
benzodiazepines causing disinhibition
substance misuse
Pharmacodynamic drug interactions
Drug interactions with antidepressants
serotonin syndrome
swapping and stopping antidepressants
Pharmacodynamic drug interactions with alcohol
Pharmacodynamic interactions with alcohol
Pharmacodynamics
changes in older people
nonspecific effects
Pharmacogenetics
Pharmacokinetic drug interactions
Pharmacokinetic interactions: a brief summary of important interactions
Pharmacokinetics
changes in older people
cytochrome function
depot antipsychotics
drug interactions with alcohol
half-life increased in hepatic impairment
impaired drug absorption following bariatric surgery
menopause effects
plasma level monitoring of psychotropic drugs
Pharmacological management chart
Pharmacological options in inappropriate sexual behaviour in older adults
Pharmacological treatment of mental and behavioural symptoms in Huntington's disease (HD)
Pharmacological treatments of bipolar depression in children and adolescents
Pharmacological treatments of mania in children and adolescents
Phenothiazines, in overdose
Phenytoin, target range
Phosphate in blood, psychotropic effects
Physical monitoring
Carbamazepine
Lithium
Valproate
Physiological risk factors
Physiological risk factors for QTc prolongation and arrhythmia
Pilosinart
Hepatic impairment
Psychotropics in overdose
Renal impairment
Pimavanserin
Antipsychotics - minimum effective doses
Equivalent doses
psychiatric adverse effects of treatments
Quick reference for licensed maximum doses
Switching antipsychotics
Placebo and nocebo effects, patient expectations of treatment
Plasma drug levels, elevated due to reduced hepatic blood flow
Plasma glucose levels, antipsychotic medication monitoring
Plasma level monitoring
Acting on clozapine plasma concentration results
Plasma level monitoring of psychotropic drugs
Refresh
first
prev
1
2
3
4
5
6
30
select
next
last
Displaying items 31 - 60 of 152